Pets at Home follows guidance perfectly
Pets at Home Group PLC (LSE:PETS) posted profits bang in line with expectations and reiterated its guidance for the year ahead. The pet store and veterinary services chain reported flat statutory revenue of £1.5 billion for the year to 27 March 2025, with statutory profit before tax rising 14% to £120.6 million.
Pets at Home falls 8.7% amid NI headwind and consumer caution; brokers unsurprised
Pets at Home Group PLC (LSE:PETS) shares fell 8.7% on Monday after the retailer lowered its profit forecast for the year ahead, blaming rising costs and continued consumer caution. The group now expects underlying pre-tax profit for the next financial year to fall to between £115 million and £125 million, down from this year's expected £133 million.
Pets at Home tumbles on warning of lower profits for year ahead
Pets at Home Group PLC (LSE:PETS) shares dropped 11.3% after the retailer and vet chain reported trading in line with expectations but gave weak guidance for the new financial year. A pre-close trading update from the FTSE 250-listed group revealed a "challenging and volatile UK consumer backdrop" but that fourth-quarter trading in both the Retail and Vets businesses was broadly as expected.
Pets at Home perks up on takeover speculation
Pets at Home Group PLC (LSE:PETS) scampered 14% higher on Wednesday on the back of takeover rumours, though the shares curled up for a rest by mid-afternoon. The pet supplies and veterinary services chain was the subject of takeover rumours in the City, with private equity mentioned.
PetMed Express, Inc. (PETS) Q3 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS ) Q3 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Reed Anderson - IR, ICR Sandra Campos - CEO and President Robyn D'Elia - CFO Conference Call Participants Erin Wright - Morgan Stanley Ryan Meyers - Lake Street Capital Markets Operator Greetings and welcome to PetMed Express Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Pets at Home to sell first pet food made from 'cultivated meat'
Pets at Home Group PLC (LSE:PETS) said it is the first company in the world to sell lab-grown meat for pet food, after 'Chick Bites' went on sale in limited release at one of its stores, in west London. Chick Bites are made from plant-based ingredients and cultivated meat, by manufacturer Meatly, and gained the regulatory green light from the Department for Environment, Food and Rural Affairs (Defra) and the Animal and Plant Health Agency last summer.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pets at Home results ‘highly unlikely to help' valuation, says Peel Hunt
Pets at Home Group PLC (LSE:PETS)'s first-half profit before tax exceeded Peel Hunt's forecasts today, although the broker acknowledged that a full-year profit downgrade will offset the perceived positives. “The shares are not on a big valuation, in our view, but have not had any positive forecast for a while and this is highly unlikely to help,” said analysts.
Pets at Home shares drop 8% after profit downgrade and Budget hit
Shares in Pets at Home Group PLC (LSE:PETS) fell 8% in early trading after the company lowered its full-year profit guidance. The retailer blamed subdued growth in the pet retail market, which it now expects to persist through the second half of its financial year.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PetMed Express: Why (And Why Not) The Rebound Could Continue
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance.
